Cargando…
Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
Mucormycosis is a severe opportunistic fungal infection caused by Mucorales. The majority of the affected patients have a history of immunosuppression, with a reported incidence of 4–19% in the immunocompetent. Early recognition and diagnosis, combined with surgical debridement and appropriate antif...
Autores principales: | Ilharco, Marta, Pereira, Carla Maravilha, Moreira, Laura, Proença, Ana Luísa, do Carmo Fevereiro, Maria, Lampreia, Fátima, Oliveira, Miguel Lopes, Rola, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700484/ https://www.ncbi.nlm.nih.gov/pubmed/31453100 http://dx.doi.org/10.1016/j.idcr.2019.e00591 |
Ejemplares similares
-
Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016) -
Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2019) -
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016) -
Isavuconazole: A Promising Salvage Therapy for Invasive Mucormycosis
por: Shafiq, Muhammad, et al.
Publicado: (2018) -
Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
por: Huggins, Jonathan, et al.
Publicado: (2018)